GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » Cyclically Adjusted FCF per Share

PT Merck Tbk (ISX:MERK) Cyclically Adjusted FCF per Share : Rp160.56 (As of Mar. 2025)


View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Merck Tbk's adjusted free cash flow per share for the three months ended in Mar. 2025 was Rp48.330. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is Rp160.56 for the trailing ten years ended in Mar. 2025.

During the past 12 months, PT Merck Tbk's average Cyclically Adjusted FCF Growth Rate was -17.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -7.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Merck Tbk was -0.80% per year. The lowest was -13.60% per year. And the median was -4.75% per year.

As of today (2025-05-27), PT Merck Tbk's current stock price is Rp3610.00. PT Merck Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was Rp160.56. PT Merck Tbk's Cyclically Adjusted Price-to-FCF of today is 22.48.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Merck Tbk was 34.20. The lowest was 6.86. And the median was 19.79.


PT Merck Tbk Cyclically Adjusted FCF per Share Historical Data

The historical data trend for PT Merck Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Cyclically Adjusted FCF per Share Chart

PT Merck Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 198.70 180.52 185.84 193.85 141.34

PT Merck Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 194.25 201.13 152.31 141.34 160.56

Competitive Comparison of PT Merck Tbk's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Cyclically Adjusted Price-to-FCF falls into.


;
;

PT Merck Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Merck Tbk's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=48.33/131.9484*131.9484
=48.330

Current CPI (Mar. 2025) = 131.9484.

PT Merck Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 154.154 99.766 203.881
201509 85.673 101.037 111.884
201512 89.949 102.133 116.208
201603 -41.635 102.764 -53.459
201606 -207.406 103.212 -265.151
201609 141.094 104.142 178.766
201612 148.819 105.222 186.619
201703 -175.403 106.476 -217.365
201706 158.761 107.722 194.467
201709 41.247 108.020 50.384
201712 119.103 109.017 144.156
201803 9.255 110.097 11.092
201806 360.144 111.085 427.786
201809 -104.708 111.135 -124.318
201812 59.198 112.430 69.475
201903 -74.361 112.829 -86.962
201906 -636.010 114.730 -731.460
201909 -0.824 114.905 -0.946
201912 173.819 115.486 198.597
202003 -69.313 116.252 -78.671
202006 -67.494 116.630 -76.359
202009 97.811 116.397 110.880
202012 129.529 117.318 145.682
202103 99.743 117.840 111.685
202106 124.478 118.184 138.976
202109 119.171 118.262 132.963
202112 -60.529 119.516 -66.825
202203 97.710 120.948 106.597
202206 -1.196 123.322 -1.280
202209 -43.211 125.298 -45.504
202212 147.899 126.098 154.761
202303 129.089 126.953 134.169
202306 78.909 127.663 81.558
202309 97.516 128.151 100.405
202312 105.139 129.395 107.214
202403 10.969 130.607 11.082
202406 46.585 130.792 46.997
202409 -7.887 130.361 -7.983
202412 37.118 131.432 37.264
202503 48.330 131.948 48.330

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


PT Merck Tbk  (ISX:MERK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

PT Merck Tbk's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=3610.00/160.56
=22.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Merck Tbk was 34.20. The lowest was 6.86. And the median was 19.79.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Merck Tbk Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk Business Description

Industry
Traded in Other Exchanges
N/A
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines